As of 2025-07-11, the EV/EBITDA ratio of Guardant Health Inc (GH) is -18.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GH's latest enterprise value is 6,771.75 mil USD. GH's TTM EBITDA according to its financial statements is -371.54 mil USD. Dividing these 2 quantities gives us the above GH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.3x - 12.5x | 9.4x |
| Forward P/E multiples | 10.7x - 14.7x | 13.0x |
| Fair Price | (35.46) - (40.74) | (37.11) |
| Upside | -169.1% - -179.4% | -172.3% |
| Date | EV/EBITDA |
| 2025-07-10 | -18.23 |
| 2025-07-09 | -18.14 |
| 2025-07-08 | -18.07 |
| 2025-07-07 | -17.64 |
| 2025-07-03 | -17.96 |
| 2025-07-02 | -17.86 |
| 2025-07-01 | -18.03 |
| 2025-06-30 | -18.48 |
| 2025-06-27 | -18.08 |
| 2025-06-26 | -17.81 |
| 2025-06-25 | -17.76 |
| 2025-06-24 | -17.79 |
| 2025-06-23 | -17.31 |
| 2025-06-20 | -17.51 |
| 2025-06-18 | -17.99 |
| 2025-06-17 | -17.64 |
| 2025-06-16 | -17.56 |
| 2025-06-13 | -17.56 |
| 2025-06-12 | -17.47 |
| 2025-06-11 | -17.47 |
| 2025-06-10 | -17.83 |
| 2025-06-09 | -17.64 |
| 2025-06-06 | -17.15 |
| 2025-06-05 | -17.27 |
| 2025-06-04 | -17.05 |
| 2025-06-03 | -16.39 |
| 2025-06-02 | -15.16 |
| 2025-05-30 | -14.67 |
| 2025-05-29 | -13.98 |
| 2025-05-28 | -13.86 |
| 2025-05-27 | -14.18 |
| 2025-05-23 | -13.79 |
| 2025-05-22 | -13.48 |
| 2025-05-21 | -13.49 |
| 2025-05-20 | -14.45 |
| 2025-05-19 | -14.54 |
| 2025-05-16 | -14.69 |
| 2025-05-15 | -14.62 |
| 2025-05-14 | -14.70 |
| 2025-05-13 | -14.92 |
| 2025-05-12 | -15.02 |
| 2025-05-09 | -15.04 |
| 2025-05-08 | -15.02 |
| 2025-05-07 | -14.37 |
| 2025-05-06 | -15.11 |
| 2025-05-05 | -15.81 |
| 2025-05-02 | -16.75 |
| 2025-05-01 | -17.42 |
| 2025-04-30 | -16.87 |
| 2025-04-29 | -17.64 |